MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells
Ziv Versano(Edmond and Lily Safra Children's Hospital), Michal Yalon(Sheba Medical Center)
Cited by 15
Related Papers
Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations
|PLoS ONE|2016|24
Pediatric glioblastoma - unlike normal cells - are sensitive to the combination of vorinostat and olaparib and to its downstream effector - phosphorylated eIF2α
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0